ArticlePloS one2012

Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.

Shu-Pin Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.